Skip to content

The DistaSense VITALS Study

DistaSense: Two-Center Prospective, Non-Significant Risk (NSR) Study to Evaluate Heart Rate and Respiratory Rate Performance for Life Detection Technologies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07217327
Acronym
VITALS
Enrollment
20
Registered
2025-10-15
Start date
2025-08-13
Completion date
2025-11-30
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of Heart Rate and Respiratory Rate

Brief summary

A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.

Interventions

DIAGNOSTIC_TESTDistaSense and Polysomnography

All subjects will be evaluated by DistaSense and reference device for respiratory rate and heart rate.

Sponsors

Nilo Medical Consulting Group
CollaboratorUNKNOWN
Life Detection Technologies
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age ≥ 22 years 2. Fluent in English 3. Willing and cognitively able to provide informed consent 4. BMI \< 36 5. Expected by the investigator to achieve sufficient sleep duration for a minimum of 4 hours of meaningful data (e.g., absence of significant insomnia) 6. Able to complete the scripted portion of the evaluation

Exclusion criteria

1. Pregnant 2. Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment 3. Subjects with electronic implants of any kind (e.g. pacemaker) 4. Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder

Design outcomes

Primary

MeasureTime frame
Accuracy and bias between the DistaSense measurements of heart rate and respiratory rate and the reference measurementsDay 1

Secondary

MeasureTime frame
Mean absolute relative difference for each of HR and RR between the DistaSense and the referenceDay 1
Deming regression for each of the HR and RR dataDay 1

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026